Tridek-One
Tridek-One develops first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases
Name
# Contributions
Last Contribution
Find more companies like Tridek-One
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.